Cargando…

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents about 60% of all adult primary brain tumors. It is notorious for its extremely low (~5%) 5-year survival rate which signals the unsatisfactory results of the standard protocol for GB therapy. This issue has beco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attia, Noha, Mashal, Mohamed, Pemminati, Sudhakar, Omole, Adekunle, Edmondson, Carolyn, Jones, Will, Priyadarshini, Priyanka, Mughal, Temoria, Aziz, Pauline, Zenick, Blesing, Perez, Ambar, Lacken, Morgan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750228/ https://www.ncbi.nlm.nih.gov/pubmed/35011678 http://dx.doi.org/10.3390/cells11010116

Ejemplares similares

Methylcobalamin in Vitamin B(12) Deficiency: To Give or not to Give?
por: Kamath, Ashwin, et al.
Publicado: (2017)

An Integrated Review of Carpal Tunnel Syndrome: New Insights to an Old Problem
por: Omole, Adekunle E, et al.
Publicado: (2023)

Small Centers with Big Ventures: Autologous Stem Cell Transplantation Survival Data
por: Abid, Muhammad Bilal, et al.
Publicado: (2019)

Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects
por: Attia, Noha, et al.
Publicado: (2021)

A preclinical model of glioblastoma
Publicado: (2015)

Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers
por: Mashal, Mohamed, et al.
Publicado: (2023)

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
por: Di Sebastiano, Andrea R., et al.
Publicado: (2018)

Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications
por: Omole, Adekunle Ebenezer, et al.
Publicado: (2018)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Medical Education During COVID-19 Pandemic: A Comparative Effectiveness Study of Face-to-Face Traditional Learning Versus Online Digital Education of Basic Sciences for Medical Students
por: Omole, Adekunle E, et al.
Publicado: (2023)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
por: Bastiancich, Chiara, et al.
Publicado: (2021)

Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
por: Davy, Mélodie, et al.
Publicado: (2023)

Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2023)

Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
por: Ahmed, Munazza, et al.
Publicado: (2022)

Epigenetic Mechanisms: New Targets for Heart Failure Pharmacopuncture
por: Volkova, Yulia A, et al.
Publicado: (2016)

The role of specimen banking in risk assessment.
por: Zenick, H, et al.
Publicado: (1995)

Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study
por: Shivaprakash, G., et al.
Publicado: (2017)

New Approach to Combat Glioblastoma Shows Promise in Preclinical Studies
Publicado: (2006)

Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
por: Mecca, Carmen, et al.
Publicado: (2018)

Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
por: Novy, Zbynek, et al.
Publicado: (2019)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020)

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
por: Ruiz-Molina, Daniel, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
por: Jasleen, Bains, et al.
Publicado: (2023)

Aging and the Environment: A Research Framework
por: Geller, Andrew M., et al.
Publicado: (2005)

Targeting the neural stem cells in subventricular zone for the treatment of glioblastoma: an update from preclinical evidence to clinical interventions
por: Li, Sijia, et al.
Publicado: (2023)

Restricted Blood Flow Exercise in Sedentary, Overweight African-American Females May Increase Muscle Strength and Decrease Endothelial Function and Vascular Autoregulation
por: Bond, Vernon, et al.
Publicado: (2017)

Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model
por: Mathios, Dimitrios, et al.
Publicado: (2015)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook
por: Zhai, Kevin, et al.
Publicado: (2021)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Nonlinear Conte-Zbilut-Federici (CZF) Method of Computing LF/HF Ratio: A More Reliable Index of Changes in Heart Rate Variability
por: Bond Jr, Vernon, et al.
Publicado: (2016)

qEEG Measures of Attentional and Memory Network Functions in Medical Students: Novel Targets for Pharmacopuncture to Improve Cognition and Academic Performance
por: Gorantla, Vasavi R., et al.
Publicado: (2019)

Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease
por: Awosika, Ayoola, et al.
Publicado: (2023)

Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study
por: De Meulenaere, Valerie, et al.
Publicado: (2019)

Spermatotoxicity associated with acute and subchronic ethoxyethanol treatment.
por: Zenick, H, et al.
Publicado: (1984)

Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
por: Ferrari, Cristina, et al.
Publicado: (2015)

A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice
por: Swenson, Steve, et al.
Publicado: (2018)

Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma
por: Augur, Zachary M., et al.
Publicado: (2018)

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ihp8h83s386suo4l9pata6g85n